Antikor Management / Research & Development

Dr Mahendra Deonarain, Chief Scientitic Officer, Co-Founder. See 'Board of Directors'.

Dr Gokhan Yahioglu, Director of Chemistry, Co-Founder. 

Dr Yahioglu has over 20 years’ experience  in the development of targeted therapies and diagnostics in oncology. Prior to Antikor, Dr Yahioglu was co-founder of PhotoBiotics an Imperial College spin-out where he led the chemistry and help develop the companies antibody targeting technology. He has held post-doctoral positions and both Cambridge University and Imperial College and is a highly cited medicinal chemist with over 60 peer-reviewed papers and granted patents.

Dr Till Medinger, Chairman of the Board. See 'Board of Directors'.

Dr Elizabeth Rollinson, Chairwoman of the Scientific Advisory Board. See 'Board of Directors'.

Dr Carlos Pittol, Chief Business Officer. See 'Board of Directors'.

Research and Development Team (left to right)

Mahendra Deonarain (CSO), Ashleigh Stewart (Cell Biologist), Anja Pomowski (Senior Scientist, Antibody Engineering and Production), Gokhan Yahioglu (Director of Chemistry), Soraya Diez-Posada (Senior Scientist, Cell Biology), Bryan Edwards (Head of Antibody Discovery), Ioannna Stamati (Team Leader, Bioconjugation and Analyses), Eifion Robertson (Senior Scientist, Synthetic Chemistry)